However, the most likely explanation is due to the fact that BM cells (including LT-HSCs, ST-HSCs, MPPs, CMPs, GMPs, and MEPs) were used as donors for the BCR-ABL transformation in the BCR-ABL induced CML model. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.